자궁 내막증 공장, 좋은 품질을 사다 자궁 내막증 상품 중국에서

1-[2-플루오로-6- ((트리플루로메틸) 벤질]-5-요도-6-메틸피리미딘-2,4 ((1H,3H) 다이온 (1150560-54-5)

1-[2-fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione is an intermediate of Elagolix Sodium. Product Name: 1-[2-fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione CAS No.: 1150560-54-5 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H9F4IN2O2 Molecular Weight: 428.12 Shelf Life: 2 Years Package: 25kg/drum

5-브로모-1-(2-플루로-6-트리플루로메틸-벤질) -6-메틸-1H-피리미딘-2,4-디온 (830346-48-0)

5-Bromo-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione is an intermediate of Elagolix Sodium. Product Name: 5-Bromo-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione CAS No.: 830346-48-0 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H9F4BrN2O2 Molecular Weight: 381.12 Shelf Life: 2 Years Package: 25kg/drum

5- ((2-플루오로-3-메토시페닐)-1-[[2-플루오로-6- ((트리플루오로메틸) 페닐]메틸]-6-메틸-2,4 ((1H,3H) -피리미딘 (1150560-59-0)

5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione is an intermediate of Elagolix Sodium. Product Name: 5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidin CAS No.: 1150560-59-0 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C20H15F5N2O3 Molecular Weight: 426.34 Shelf Life: 2 Years Package: 25kg/drum

벤젠에시트산, 4-플루로-알파- ((1-메틸에틸) -, (. 알파.S) - (830346-47-9)

Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)- is a key intermediate of Elagolix Sodium. Product Name: Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)- CAS No.: 830346-47-9 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H10F4N2O2 Molecular Weight: 302.22 Shelf Life: 2 Years Package: 25kg/drum

엘라골릭스 나트륨 (832720-36-2)

Elagolix sodium (ABT-620) is a small molecule, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist. It has the ability to suppress estradiol (E2) concentrations in a dose-dependent manner. Elagolix is the first orally available GnRH antagonist, and as such may provide patients with relief from the painful symptoms of endometriosis while offering advantages over currently available injectable peptide-based treatments. The estimated patient population is

2-플루로-3-메토시페닐보론산 (352303-67-4)

2-fluoro-3-methoxyphenylboronic acid is an intermediate of Elagolix Sodium. Product Name: 2-fluoro-3-methoxyphenylboronic acid CAS No.: 352303-67-4 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C7H8BFO3 Molecular Weight: 169.95 Shelf Life: 2 Years Package: 25kg/drum